cobaltous chloride has been researched along with Anterior Cerebral Circulation Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Feng, H; Hu, J; Hu, SL; Li, B; Li, JT; Lin, JK; Qian, ZM; Wei, LJ; Yang, YF; Zhu, G | 1 |
1 other study(ies) available for cobaltous chloride and Anterior Cerebral Circulation Infarction
| Article | Year |
|---|---|
Interleukin-1 receptor associated kinases-1/4 inhibition protects against acute hypoxia/ischemia-induced neuronal injury in vivo and in vitro.
Topics: Animals; Apoptosis; Brain Infarction; Caspase 3; Cells, Cultured; Cerebral Cortex; Cobalt; Disease Models, Animal; Enzyme Inhibitors; Humans; Hypoxia-Ischemia, Brain; Infarction, Middle Cerebral Artery; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Male; Neurons; Neuroprotective Agents; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor-alpha | 2011 |